Group structure
5 companies in 3 countries
Canada1
Italy1
United States1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading your pageโฆ
5 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 42
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BYSANTI10mg | 12mg | 1mg | 2mg | 4mg | 6mg | 8mg ยท Tablet | Milsaperidone | United States | Marketed | 2026 |
| FANAPT10mg | 12mg | 1mg | 2mg | 4mg | 6mg | 8mg ยท Tablet | Iloperidone | United States | Marketed | 2009 |
| Hetlioz | Tasimelteon | EU (EMA) | Authorised | 2015 |
| HETLIOZ20mg ยท Capsule | Tasimelteon | United States | Marketed | 2014 |
| HETLIOZCapsula rigida | Tasimelteon | Italy | Authorised | |
| Hetlioz 20 mg harde capsulesCapsule, hard | Tasimelteon | Netherlands | Authorised | 2015 |
| HETLIOZ LQ4mg/ml ยท Suspension | Tasimelteon | United States | Marketed | 2020 |
| NEREUS85mg ยท Capsule | Tradipitant | United States | Marketed | 2025 |
| PONVORY20 mg ยท Tablet | Ponesimod | Canada | Marketed | 2021 |
| PONVORY10mg | 20mg | 2mg | 3mg | 4mg | 5mg | 6mg | 7mg | 8mg | 9mg ยท Tablet | Ponesimod | United States | Marketed | 2021 |
| PONVORY8 mg + 3 mg + 9 mg + 5 mg + 7 mg + 10 mg + 4 mg + 6 mg + 2 mg ยท Tablet | Ponesimod | Canada | Not marketed | 2021 |
| HEPATINE VANDA COMPOSITUMCapsula rigida | Italy | Authorised | ||
| VANDA 1Granuli | Belladonna, Eupatorium perfoliatum, Aconitum napellus, Arnica montana, Gelsemium sempervirens, Sulfur | Italy | Authorised | |
| VANDA 11Granuli | Passiflora incarnata, Selenium, Argentum nitricum, Gelsemium sempervirens, Coffee, Bromatum, Ignatia, Phosphoric acid | Italy | Authorised | |
| VANDA 12Granuli | Belladonna, Sulphur iodatum, Hydrocotyle asiatica, Hepar sulfur, Bromatum, Rhus, Iodate, Silicea | Italy | Authorised | |
| VANDA 15Granuli | Aloe, Nux vomica, Citrullus colocynthis, Gelsemium sempervirens, Podophyllum peltatum, Veratrum album, Arsenicum album, Chamomilla | Italy | Authorised | |
| VANDA 17Gocce orali, soluzione | Lithium carbonicum, Ledum palustre, Benzoic acid, Bryonia, Colchicum autumnale, Rhododendron aureum, Dulcamara, Rhus | Italy | Authorised | |
| VANDA 2Granuli | Valeriana officinalis, Phosphoric acid, Gelsemium sempervirens, Hyoscyamus niger, Magnesia carbonica | Italy | Authorised | |
| VANDA 21Granuli | Italy | Authorised | ||
| VANDA 23Granuli | Italy | Authorised | ||
| VANDA 25Granuli | Viburnum opulus, Secale cornutum, Citrullus colocynthis, Conium maculatum, Hamamelis virginiana, Pulsatilla pratensis, Magnesia phosphorica, Chamomilla | Italy | Authorised | |
| VANDA 26Granuli | Ipeca, Nux vomica, Tabacum, Petroleum, Cocculus | Italy | Authorised | |
| VANDA 29Gocce orali, soluzione | Belladonna, Ledum palustre, Aconitum napellus, Arnica montana, Colchicum autumnale, Hypericum perforatum, Cina | Italy | Authorised | |
| VANDA 32Gocce orali, soluzione | Causticum hahnemanni, Nitric acid, Thuya occidentalis, Antimonium crudum, Cinnabaris | Italy | Authorised | |
| VANDA 37Granuli | Hydrastis canadensis, Bichromicum, Teucrium marum, Mercurius solubilis, Cinnabaris, Silicea, Allium cepa | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 29 | 29 | 0 | CompaniesAll medicines |
| United States | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 4 | 1 | 3 | CompaniesAll medicines |
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
| Netherlands | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.